These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 27726125

  • 1. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Wong SC, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
    [Abstract] [Full Text] [Related]

  • 2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 3. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD003594. PubMed ID: 21069676
    [Abstract] [Full Text] [Related]

  • 4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Habashy D, Craig JC.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003594. PubMed ID: 16625586
    [Abstract] [Full Text] [Related]

  • 5. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
    [Abstract] [Full Text] [Related]

  • 6. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D, Hodson E, Craig J.
    Cochrane Database Syst Rev; 2004 Apr 16; (2):CD003594. PubMed ID: 15106208
    [Abstract] [Full Text] [Related]

  • 7. Interventions for focal segmental glomerulosclerosis in adults.
    Hodson EM, Sinha A, Cooper TE.
    Cochrane Database Syst Rev; 2022 Feb 28; 2(2):CD003233. PubMed ID: 35224732
    [Abstract] [Full Text] [Related]

  • 8. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2013 Oct 29; (10):CD002290. PubMed ID: 24166716
    [Abstract] [Full Text] [Related]

  • 9. Interventions for minimal change disease in adults with nephrotic syndrome.
    Azukaitis K, Palmer SC, Strippoli GF, Hodson EM.
    Cochrane Database Syst Rev; 2022 Mar 01; 3(3):CD001537. PubMed ID: 35230699
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.
    Cochrane Database Syst Rev; 2018 Jun 29; 6(6):CD002922. PubMed ID: 29957821
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive agents for treating IgA nephropathy.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Mar 12; 3(3):CD003965. PubMed ID: 32162319
    [Abstract] [Full Text] [Related]

  • 12. Interventions for preventing and treating kidney disease in IgA vasculitis.
    Hahn D, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2023 Feb 28; 2(2):CD005128. PubMed ID: 36853224
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ.
    Cochrane Database Syst Rev; 2021 Nov 15; 11(11):CD004293. PubMed ID: 34778952
    [Abstract] [Full Text] [Related]

  • 14. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Aug 07; 2015(8):CD005128. PubMed ID: 26258874
    [Abstract] [Full Text] [Related]

  • 15. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002290. PubMed ID: 18254005
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2024 Aug 22; 8(8):CD001533. PubMed ID: 39171624
    [Abstract] [Full Text] [Related]

  • 17. Interventions for steroid-resistant nephrotic syndrome: a systematic review.
    Habashy D, Hodson EM, Craig JC.
    Pediatr Nephrol; 2003 Sep 22; 18(9):906-12. PubMed ID: 12836096
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.
    Cochrane Database Syst Rev; 2014 Oct 16; 2014(10):CD004293. PubMed ID: 25318831
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292
    [Abstract] [Full Text] [Related]

  • 20. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002290. PubMed ID: 15846634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.